Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DiverseFarm is a Japanese biotechnology company specializing in the discovery of functional peptides and proteins using its proprietary Stable-cDNA display technology. The platform enables the rapid screening of massive libraries containing over 10 trillion variants to identify high-affinity ligands for challenging drug targets, such as G protein-coupled receptors (GPCRs) and protein-protein interactions. By ensuring a robust covalent link between the phenotype and genotype, the company overcomes the stability limitations of traditional mRNA display methods. DiverseFarm primarily operates as a platform-driven discovery partner, collaborating with pharmaceutical companies to develop next-generation biotherapeutics. Their approach is designed to accelerate the identification of lead candidates for oncology, immunology, and other complex therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diverse Farm.